.OncoC4 is taking AcroImmune-- and also its in-house clinical production functionalities-- under its...
.Amgen has discussed (PDF) the initial phase 3 records on its $400 thousand chronic eczema medicine,...
.Biogen and UCB's gamble on developing into phase 3 astride an unsuccessful research tries to have a...
.Italian biotech Aptadir Therapeutics has actually launched with the assurance that its own pipe of ...
.Wave Lifestyle Sciences has actually satisfied its own goal in a Duchenne muscle dystrophy (DMD) st...
.After a few years in biotech, Mike Quigley, Ph.D., is actually going back to the pharma layer, taki...
.Achilles Rehabs has shreded its technique. The English biotech is actually stopping work on its cli...
.Aligos Therapeutics is actually trumpeting a midstage gain in metabolic-dysfunction associated stea...
.Basilea Pharmaceutica's job creating brand-new antifungals has actually received a considerable boo...
.Possessing presently gathered up the U.S. liberties to Capricor Rehabs' late-stage Duchenne muscula...